Skip to main content

Organon & Co.

OGN
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0001821825

In the last 90 days, Organon & Co. insiders filed 0 open-market purchases and 1 sale; 636 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Organon & Co. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
1 filing
1 insider, $200.3K in total
Insiders trading
1
Net value
−$200.3K
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Organon & Co., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Organon & Co.
NameTitleLast reported holdingLast filingFilings, past year
Arjona Ferreira Juan CamiloHead of R&D & CMO37,432Aug 12, 20264
Drinane Juliana PapaHead of Mfg & Supply18,475Aug 5, 20265
Lazarus Rochelle BDirector–Jun 15, 20261
Essner RobertDirector–Jun 15, 20261
Sharp ShaliniDirector–Jun 15, 20261
Gayle Helene DDirector–Jun 15, 20261
Patton Cynthia MDirector–Jun 15, 20261
Ezekowitz AlanDirector–Jun 15, 20261
Sequeira RamonaDirector–Jun 15, 20261
Ozuah PhillipDirector–Jun 15, 20261
Leone Deborah RDirector–Jun 15, 20261
Holzbaur LynetteSVP and Corporate Controller0May 7, 20265
Walsh Matthew MChief Financial Officer212,746Apr 2, 20263
Stahler Rachel AChief Information Officer116,105Apr 2, 20263
Karp DanielExecutive VP, Corp. Dev.69,548Apr 2, 20262
Falcione AaronChief Human Resources Officer101,431Apr 2, 20263
Morrissey Joseph T. Jr.Interim CEO123,123Apr 2, 20264
Nisita VittorioHead of Global Business Svcs70,619Apr 2, 20263
Weaver KirkeGen. Counsel & Corp. Secy.92,639Apr 2, 20263
Cox Carrie SmithExecutive Chair77,869IndirectNov 13, 20251
Whiteford Grace PumaDirector–Jun 16, 20250
Ali KevinChief Executive Officer282,731May 6, 20250
DiMarco KathrynCorporate Controller38,740Apr 2, 20250
Fiedler SusanneChief Commercial Officer53,113Sep 5, 20240
McGarry Martha EDirector–Jun 11, 20240
Francisco Ma. FatimaDirector3,000Jun 13, 20230
Ritter Geralyn SHead of Ext. Affairs and ESG10,755May 8, 20230
Milligan SandraHead of Research & Development28,599May 8, 20230
Telman Deborah HEVP GC & Corporate Secretary7,688May 5, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Aug 5, 2026 (view filing)4:04 PM ETAug 5Same dayDrinane Juliana PapaHead of Mfg & SupplySSale−14.8K$13.57−$200.3K−44.4%18.5K after
May 7, 2026 (view filing)May 61 dayHolzbaur LynetteSVP and Corporate ControllerSSale−26.4K$13.35−$353.1K−100.0%0 afterAmended
Nov 13, 2025 (view filing)Nov 121 dayCox Carrie SmithExecutive ChairPPurchase+65.4K$7.67+$501.6K+524.5%77.9K after
May 15, 2025 (view filing)May 141 dayCox Carrie SmithDirectorPPurchase+12.5K$8.07+$100.6KNew position12.5K after
May 7, 2025 (view filing)May 7Same dayFalcione AaronChief Human Resources OfficerPPurchase+5.50K$8.77+$48.2K+9.6%63.0K after
May 7, 2025 (view filing)May 61 dayWeaver KirkeGen. Counsel & Corp. Secy.PPurchase+8.04K$9.21+$74.1K+18.1%52.5K after
May 7, 2025 (view filing)May 61 dayKarp DanielExecutive VP, Corp. Dev.PPurchase+3.50K$8.24+$28.8K+8.1%46.7K after
May 6, 2025 (view filing)May 51 dayWalsh Matthew MChief Financial OfficerPPurchase+11.4K$8.82+$100.5K+8.6%144.5K after
May 6, 2025 (view filing)May 51 dayAli KevinChief Executive OfficerPPurchase+34.0K$8.81+$299.5K+13.7%282.7K after
Feb 23, 2024 (view filing)Feb 221 dayWeaver KirkeGen. Counsel & Corp. Secy.PPurchase+2.72K$18.36+$49.9K+21.8%15.2K after
Aug 19, 2021 (view filing)Aug 19Same dayFrancisco Ma. FatimaDirectorPPurchase+3.00K$33.79+$101.4KNew position3.00K after